Wills Robert James — SEC insider filings
SEC reporting owner CIK 1634189. 25 insider filings on record with FilingPulse; latest filed 2026-08-24.
Transaction summary — filings shown
Covers all 25 filings on record, filed 2020-10-05 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 5 filings — 50,000 shares, $383,734 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 980 shares, $8,859 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
- Largest priced transaction: purchase of 15,000 shares @ $8.49 ($127,328) in Alpha Cognition Inc., filed 2025-08-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | Director | 4 | 2 legs · 25,000 sh · $223,528 | — | 3 |
| Oncternal Therapeutics, Inc. (ONCT) | Director | 7 | 2 legs · 10,000 sh · $86,257 | 1 leg · 980 sh · $8,859 | 4 |
| Milestone Pharmaceuticals Inc. (MIST) | Director | 9 | 1 leg · 15,000 sh · $73,950 | — | 10 |
| CymaBay Therapeutics, Inc. (CBAY) | Director | 5 | — | — | 18 |
Insider filings — Wills Robert James
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4 | Alpha Cognition Inc. (ACOG) | Purchase (P): 10,000 @ $9.62 | EDGAR |
| 2026-06-12 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 77,000 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Alpha Cognition Inc. (ACOG) | Grant/award (A): 7,241 @ $0 · Grant/award (A): 8,437 (derivative) @ $0 | EDGAR |
| 2025-08-21 | 4 | Alpha Cognition Inc. (ACOG) | Purchase (P): 15,000 @ $8.49 | EDGAR |
| 2025-07-15 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 50,000 · Grant/award (A): 50,000 (derivative) · Grant/award (A): 50,000 (derivative) | EDGAR |
| 2025-06-12 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-04-09 | 4 | Alpha Cognition Inc. (ACOG) | Grant/award (A): 30,019 (derivative) @ $0 | EDGAR |
| 2024-08-29 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Grant/award (A): 2,200 (derivative) @ $0 | EDGAR |
| 2024-04-10 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Purchase (P): 3,086 @ $8.96 | EDGAR |
| 2024-04-01 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Purchase (P): 6,914 @ $8.48 | EDGAR |
| 2024-03-22 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Disposition to issuer (D): 30,000 · Disposition to issuer (D): 18,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 9,000 (derivative) · Disposition to issuer (D): 27,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · +8 more | EDGAR |
| 2024-02-27 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Sale (S): 980 @ $9.04 | EDGAR |
| 2024-01-26 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Grant/award (A): 14,010 (derivative) @ $0 | EDGAR |
| 2023-06-30 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-01-27 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2022-10-21 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Purchase (P): 15,000 @ $4.93 | EDGAR |
| 2022-08-11 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-06-17 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2022-01-27 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2021-07-29 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2021-05-27 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-01-28 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2020-10-05 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1634189 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs